Exclusively WSB
Jim McNerney
Chairman, President and CEO, The Boeing Company (2005–2016); Chairman and CEO, 3M (2000–2005)
Exclusively WSB
Mark McClellan, M.D.
Fee
$25K - $40K
Exclusively WSB
Mark McClellan, M.D.
One of the most respected and forward-thinking leaders on U.S. health care policy, Dr. Mark McClellan addresses America's current and future health care challenges.
Dr. Mark McClellan, Director, Duke-Margolis Center for Health Policy
Expertise In:
- Health Care Economics
- Health Care Policy
- Innovation
Audience & Industry
- Associations
- Corporations
- The Health Care Industry
- Board Meetings and Executive Briefings
One of the most respected and forward-thinking leaders on U.S. health care policy, Dr. Mark McClellan addresses America’s current and future health care challenges.
As the only person to have led both the Food & Drug Administration and the Centers for Medicare & Medicaid Services (CMS), Mark McClellan shares with audiences a behind-the-scenes assessment of America’s health care system and what needs to be done to fix it. While overseeing a budget larger than that of the Pentagon’s at CMS, McClellan was not business as usual as he tackled one of the most important issues of our time head-on, and instituted the largest health care policy reforms in over 40 years—from the Medicare prescription drug benefit to numerous public-private initiatives—which have a profound impact on your health care future. An activist and innovator, McClellan explains what it takes to successfully navigate the medical, economic and social issues surrounding current policy, while encouraging consumers to take ownership of their treatment. As a political appointee who served under Presidents Clinton and George W. Bush, McClellan is a two-time recipient of the Arrow Award for Outstanding Research in Health Economics. In 2015, Duke University appointed McClellan the Robert J. Margolis MD Professor of Business, Medicine and Health Policy. The University additionally named McClellan its inaugural director of a new health policy center, which was founded the same year with the goal to develop and implement new health reform.
Featured Videos
Mark McClellan, M.D.
Deep Dive: Six FDA Commissioners Take the Stage (ft. Mark McClellan)
Mark McClellan, M.D.
2016 Annual Meeting Vital Directions Panel: Mark McClellan (Duke University)
Mark McClellan, M.D.
Mark McClellan MD, PhD, Director of the Duke-Robert J. Margolis, MD, Center for Health Policy
Featured Experiences
The Politics of Health Care Innovation
Innovation in health care is a long, costly and risky process, governed by guidelines and fraught with regulatory and bureaucratic challenges. In fact, it’s estimated that the cost of bringing a new drug to market is approximately $800 million. And this process requires not only good science, but effective financing and careful attention to regulatory processes to gain market approval and acceptance by public and private insurance programs. Lacking a comprehensive strategy for addressing these issues means that a valuable product may not reach patients in a timely and cost-effective way. Dr. Mark McClellan reviews some of the major challenges and opportunities for product developers and investors, including an overview of key issues at the FDA and at Medicare/Medicaid Services that impact the development and use of new medical technologies.
Reforming Medicare
Dr. Mark McClellan led the U.S. Medicare program through the implementation of the most significant reforms in its 40-year history, as Medicare added prescription drug coverage and altered its outlook to become more focused on prevention rather than on treatment. In a presentation full of potential solutions to problems posed by an aging population, McClellan reviews some of the key policy, political, administrative, communications and outreach challenges in implementing major health care reforms. He also outlines the key issues for the future of Medicare as well as initiatives to meet these challenges, as it faces funding complications from the aging baby-boom generation.
Reforming Medicaid: Covering the Uninsured and Providing for Long-Term Care
With health care costs rising alongside the numbers of uninsured Americans, providing access to affordable, up-to-date coverage is a critical priority for the country. Today, Medicaid and the State Children’s Health Insurance Program provide coverage for over 50 million low-income Americans, but rising costs and changing population needs are leading every state to re-evaluate how Medicaid services are provided. As the Chief of Medicare/Medicaid Services, Dr. Mark McClellan led the agency through the most important Medicaid reforms in the program’s 40-year history. In a compelling presentation offering possible solutions to the Medicaid crisis, McClellan reviews how states’ respond, while providing innovative approaches to dispensing Medicaid benefits, including expansions of coverage, providing “dual-eligible” (Medicare and Medicaid) coverage and long-term care reforms (such as “Money Follows the Person” benefit reform).
Driving the Conversation: A Look at the Future of Health Care in America
The state of healthcare and the ongoing implementation of the Affordable Care Act have the U.S. at a unique crossroad. As research breakthroughs result in potential cures and better treatments, patients and health professionals are frustrated by bureaucracy and other factors that drive up the costs and availability of beneficial health care even as policymakers have tried to address many of these long-standing issues. Drawing on his experience as administrator for both the Centers for Medicare & Medicaid Services and the Food & Drug Administration, Dr. Mark McClellan reviews the Affordable Care Act, what’s working, not working and all the trends in the U.S. health care system, explaining how these trends can potentially transform the health care landscape. He provides audiences with key insight on the issues shaping our health care debate and outlines specific steps—such as transparency of the system and “ownership” by its users—that public and private sectors should take to promote better care now and in the future.
